Cytokinetics CYTK
NASDAQ CYTK
$65.60 -0.02 (-0.03%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cytokinetics (CYTK) Interest & Investment Income (2012 - 2013)

Updated

Cytokinetics' Interest & Investment Income came in at $156,000 for FY2015, up 44.4% from $108,000 in FY2014.

Analysis

Cytokinetics (CYTK) Interest & Investment Income (2012 - 2013) Analysis & Trends

Going back to FY2011, Cytokinetics' Interest & Investment Income data covers 5 years.

  • Interest & Investment Income carries a four-year compound annual growth rate of 2.2% (FY2011 to FY2015).
  • The five-year range for annual Interest & Investment Income is $89,000 (FY2012) to $177,000 (FY2013).
  • Per Business Quant, earlier years put Interest & Investment Income at $108,000 in FY2014 (-39.0%), $177,000 in FY2013 (+98.9%), $89,000 in FY2012 (-37.8%) and $143,000 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Cytokinetics 9.12 Bn 5.29 Bn 25.89 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 101,000.00
Sep 30, 2013 24,000.00
Jun 30, 2013 23,000.00
Dec 31, 2012 33,000.00
Sep 30, 2012 30,000.00
Jun 30, 2012 13,000.00
API Access

Cytokinetics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CYTK&period=max&api_key=YOUR_API_KEY